Michael Davis
Advises U.S. and global companies on strategic M&A matters. Advises private equity sponsors on a full range of transactions and portfolio company matters.
Michael is a member of our Mergers & Acquisitions and Private Equity practices. He advises leading U.S. and multinational corporations on a wide variety of strategic M&A transactions and advises private equity sponsors on a full range of transactions and portfolio company matters.
He has deep experience in many types of corporate transactions, including domestic and cross-border mergers, acquisitions, investments, joint ventures and collaborations, spinoffs and restructurings. Michael also regularly provides defensive and corporate governance advice to his clients and is experienced at advising special committees on sensitive matters.
Michael was named one of “Hollywood’s Top Dealmakers of 2022” by the Hollywood Reporter.
Experience
Life Sciences
- Intra-Cellular Therapies on its $14.6 billion acquisition by Johnson & Johnson
- Endo on its $6.7 billion merger with Mallinckrodt
- Charles River Laboratories on various acquisitions, including of Cognate, Explora BioLabs, HemaCare, MPI Research, Vigene Biosciences and WIL Research and on its cooperation agreement with Elliott
- Sun Pharma on its merger with Taro
- Daiichi Sankyo on various transactions, including its $4 billion sale of Ranbaxy Laboratories
- Mitsubishi Tanabe Pharma on its $1.1 billion acquisition of NeuroDerm
Asset Management and Financials
- Citi on various matters, including its recent acquisition of Barclays American Airlines co-branded card portfolio
- Varagon Capital on its strategic partnerships with Aflac and AIG and sale to Man Group
- Sale of Cerity Partners to Genstar
- Sale of Clarion Partners to Legg Mason
- Sale of Ridgeworth to Virtus Investment Partners
- Sale of Wealth Enhancement Group to TA Associates
- Dai-ichi Life on its investment in and strategic alliance with Janus Capital
- Perella Weinberg on its sale of Agility to Cerity Partners
Tech, Media & Telecom
- Allegro MicroSystems on its defense of a hostile bid by onsemi
- Kyocera on its $1.03 billion acquisition of AVX
- Bertelsmann on various transactions, including the acquisition of full ownership and creation of Penguin Random House, formation of Sony BMG and sale of its interest, and investment in Afya
- Penguin Random House on various transactions, including its acquisition of Hay House and proposed $2.2 billion acquisition of Simon & Schuster
- ICM Partners on its sale to CAA
- Gersh on its acquisition of You First
Industrials
- Baker Hughes on various transactions, including its combination with GE’s oil and gas business and proposed sale to Halliburton
- ABB on various transactions, including its $2.6 billion acquisition of GE Industrial Solutions and divestitures
- Traton on its $3.7 billion acquisition of Navistar
Private Equity
- Lightyear Capital on various investments, including in Therapy Brands, Wealth Enhancement Group, AmpliFI, Cerity Partners, CuraLinc, Datalot, eCommission, Engage PEO, Schellman & Company, Inszone Insurance, King Risk Partners, Lighthouse, Prime Pensions, Vehlo and Ygrene
- Lightyear Capital and Ontario Teachers’ Pension Plan on the acquisitions of Allworth Financial and Lendmark
- Crestview Partners on various transactions. including its proposed take-private of WideOpenWest and investments in Arxis Capital, Gersh, ICM Partners, Key Safety Systems, Protect My Car, Select Energy, Silver Creek, NYDJ, ValueOptions and Voya Insurance and Annuity
- Metalmark Partners on various transactions, including its investments in Innovetive Petcare, Kissner Group, Morgenesis, NSC, US Salt and WorldStrides
- Bain Capital and ADIA on their acquisition of Merchants Fleet
Recognition
Chambers USA – Private Equity: Buyouts, New York
Hollywood Reporter – “Hollywood’s Top Dealmakers of 2022”
IFLR1000 – M&A, United States
LMG Life Sciences – Mergers & Acquisitions, United States
Education
- first-class honours
- University Medal
Prior experience
- London office, 2003-2004
- Associate, Mallesons Stephen Jaques, 1998
Qualifications and admissions
- State of New York